Free PSA estimation substituted by calculation where total PSA value is up to 4 ng/ml

Free PSA estimation substituted by calculation where total PSA value is up to 4 ng/ml

Bibliographic Details
Main Authors:	M Dhumne, C Sengupta, G Kadival, R Nirmala, A Rathinaswamy, A Velumani
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2006-01-01
Series:	Indian Journal of Urology
Online Access:	http://www.indianjurol.com/article.asp?issn=0970-1591;year=2006;volume=22;issue=3;spage=279;epage=280;aulast=Dhumne

Similar Items

Comparison between PSA density, free PSA percentage and PSA density in the transition zone in the detection of prostate cancer in patients with serum PSA between 4 and 10 ng/ml
by: Emerson P. Gregorio, et al.
Published: (2007-04-01)

Zonal adjusted PSA density improves prostate cancer detection rates compared with PSA in Taiwanese males with PSA < 20 ng/ml
by: Tsung-Hsin Chang, et al.
Published: (2020-10-01)

Prostate-specific Antigen (PSA) Density and Free to Total PSA Ratio in Diagnosing Prostate Cancer with Prostate-Specific Antigen Levels of 4.0 ng/ml or Less
by: Xin LIU, et al.
Published: (2015-11-01)

Comparison of percentage free PSA, MRI and GaPSMA PET scan for diagnosing cancer prostate in men with PSA between 4 and 20 ng/ml
by: Niraj Kumar, et al.
Published: (2019-01-01)

Histopathological findings in extended prostate biopsy with PSA ≤ 4 ng/mL
by: Katia R. Leite, et al.
Published: (2008-06-01)

Comparison of Pathology and Prevalence of Prostate Cancer in Patients with PSA between 4-10 ng/ml
by: A Tabibi, et al.
Published: (2008-01-01)

Prospective validation of %p2PSA and the Prostate Health Index, in prostate cancer detection in initial prostate biopsies of Asian men, with total PSA 4-10 ng ml-1
by: Lincoln GL Tan, et al.
Published: (2017-01-01)

PSA density improves the rate of prostate cancer detection in Chinese men with a PSA between 2.5-10.0 ng ml -1 and 10.1-20.0 ng ml -1 : a multicenter study
by: Yu-Rong Lin, et al.
Published: (2015-06-01)

Peripheral zone PSA density: a predominant variable to improve prostate cancer detection efficiency in men with PSA higher than 4 ng ml-1
by: Cheng Wang, et al.
Published: (2021-01-01)

Does PSA reduction after antibiotic therapy permits postpone prostate biopsy in asymptomatic men with PSA levels between 4 and 10ng/mL?
by: W. F. S. Busato, et al.
Published: (2015-04-01)

Age-Specific Cutoff Value for the Application of Percent Free Prostate-Specific Antigen (PSA) in Chinese Men with Serum PSA Levels of 4.0-10.0 ng/ml.
by: Rui Chen, et al.
Published: (2015-01-01)

Relation between Serum Level of Total PSA and Free PSA/Total PSA Ratio with Grade of Prostate Cancer
by: Mohammad Yazdani, et al.
Published: (2013-10-01)

Radical Prostatectomy as a First-Line Treatment in Patients with Initial PSA >20 ng/mL
by: Alexander I. Hinev, et al.
Published: (2012-01-01)

Stromal Tumor of Uncertain Malignant Potential (STUMP) With PSA >500 ng/ml: A Case Report
by: Michael H. Johnson, et al.
Published: (2015-09-01)

The Chances of Subsequent Cancer Detection in Patients with a PSA > 20 ng/ml and an Initial Negative Biopsy
by: Nadeem Shaida, et al.
Published: (2009-01-01)

Decision Tree Analysis for Prostate Cancer Prediction in Patients with Serum PSA 10 ng/ml or Less
by: Pantic Damjan N, et al.
Published: (2020-03-01)

Total PSA and free PSA in patients with severe liver dysfunction
by: Rama Devi Mittal, et al.
Published: (2003-01-01)

Predictive value of [-2]propsa (p2psa) and its derivatives for the prostate cancer detection in the 2.0 to 10.0ng/mL PSA range
by: I. Vukovic, et al.

The likelihood of having serum level of PSA of ≥4.0 ng/mL and ≥10.0 ng/mL in non-obese and obese Nigerian men with LUTS
by: Patrick Temi Adegun, et al.
Published: (2015-07-01)

Correlation of Serum Androgens and Pituitary Hormone Levels with Serum PSA Less Than 2.5 NG/ML
by: Mustafa Sofikerim, et al.
Published: (2007-01-01)

Frequência de Adenocarcinoma Prostático em biópsias de 12 ou 18 fragmentos de pacientes com valores de PSA total entre 2,5 e 10 ng/ml, relação PSAlivre / PSAtotal ≤ 19% e densidade do PSA ≥ 15ng/ml/cc
by: Souza, Paulo José Gonçalves de
Published: (2017)

Study of Serum Total PSA and Free PSA as an Oncological Marker in Breast Tumour
by: Elteza Tahjiba Jahir, et al.
Published: (2017-03-01)

Impact of PSA density of transition zone as a potential parameter in reducing the number of unnecessary prostate biopsies in patients with PSA levels between 2.6 and 10.0 ng/mL
by: Hugo A. Socrates Castro, et al.

Free PSA: A better molecular marker than total PSA for breast cancer
by: Rachita Nanda
Published: (2014-10-01)

Incidental prostatic adenocarcinoma in patients with PSA less than 4 ng/ml undergoing radical cystoprostatectomy for bladder cancer in iranian men
by: S.Y. Hosseini, et al.
Published: (2007-04-01)

Serum and tissue monocyte differentiation in PSA value 4–10 ng/mL prostate cancer and benign prostatic hyperplasia
by: Yuanyuan Guo, et al.
Published: (2018-11-01)

Contribuição da densidade do PSA para predizer o câncer da próstata em pacientes com valores de PSA entre 2,6 e 10,0 ng/ml
by: Hugo Alexandre Sócrates de Castro, et al.
Published: (2011-08-01)

The sufficiency of 6 core sextant prostate biopsy in patients with prostate specific antigen (PSA) values over 20 ng/mL
by: Cem Yücel, et al.
Published: (2018-06-01)

Urinary Biomarker Panel to Improve Accuracy in Predicting Prostate Biopsy Result in Chinese Men with PSA 4–10 ng/mL
by: Yongqiang Zhou, et al.
Published: (2017-01-01)

PSA levels of 4.0 - 10 ng/ml and negative digital rectal examination: antibiotic therapy versus immediate prostate biopsy
by: Avraham Shtricker, et al.
Published: (2009-10-01)

Developing a follow-up strategy for patients with PSA ranging from 4 to 10 ng/ml via a new model to reduce unnecessary prostate biopsies.
by: Ruizhe Zhao, et al.
Published: (2014-01-01)

Detection of prostate cancer with complexed PSA and complexed/total PSA ratio - is there any advantage?
by: Strittmatter F, et al.
Published: (2011-10-01)

Tumor characteristics, treatments, and survival outcomes in prostate cancer patients with a PSA level < 4 ng/ml: a population-based study
by: Zhibo Zheng, et al.
Published: (2020-04-01)

Predictive factors of prostate cancer diagnosis with PSA 4.0–10.0 ng/ml in a multi-ethnic Asian population, Malaysia
by: Raymond Shi Liang Yii, et al.
Published: (2020-01-01)

Prostate Health Index (PHI) improves prostate cancer detection at initial biopsy in Taiwanese men with PSA 4–10 ng/mL
by: Po-Fan Hsieh, et al.
Published: (2018-08-01)

A Comparative Performance Analysis of Total PSA, Percentage Free PSA, PSA Velocity, and PSA Density versus the Detection of Primary Circulating Prostate Cells in Predicting Initial Prostate Biopsy Findings in Chilean Men
by: Nigel P. Murray, et al.
Published: (2014-01-01)

Metastatic Mucinous Adenocarcinoma of the Prostate with PSA Value of 8.6 ng/mL at 5-Year-Followup after Prostatectomy, Radiotherapy, and Androgen Deprivation
by: Christos Kalaitzis, et al.
Published: (2014-01-01)

Performance of PSA and of PSA density in the diagnosis of prostate carcinoma
by: Antonio Carlos Pereira Martins, et al.
Published: (2002-01-01)

Defining intermediate-risk prostate cancer suitable for active surveillance with PSA 10-20ng/ml: Pathological outcome analysis of a population-level dataset
by: P.E. Lonergan, et al.
Published: (2020-07-01)

AGE, TOTAL PSA, PSA DENSITY AND GLEASON SCORE, TAUS AS PREDICTIVE FACTORS IN PATIENTS WITH PROSTATE CANCER
by: Daruqutni Albar, et al.
Published: (2016-03-01)